Atai Life Sciences N.V. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported net loss was USD 33.14 million compared to USD 36.87 million a year ago. Basic loss per share from continuing operations was USD 0.21 compared to USD 0.24 a year ago.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.675 USD | -3.18% | -12.04% | +19.15% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+19.15% | 290M | |
+44.06% | 54.04B | |
+43.57% | 41.96B | |
-1.38% | 41.92B | |
-7.59% | 28.35B | |
+12.12% | 26.35B | |
-21.89% | 19B | |
+7.41% | 13B | |
+29.45% | 12.28B | |
+25.51% | 12.19B |
- Stock Market
- Equities
- ATAI Stock
- News Atai Life Sciences N.V.
- Atai Life Sciences N.V. Reports Earnings Results for the First Quarter Ended March 31, 2023